NCT01857024
Post Authorisation Safety Study of Renvela® in Chronic Kidney Disease Patients Not on Dialysis With Hyperphosphataemia Not Available Not Available completed NCT01424787
Non-interventional Study to Evaluate the Ease of Reaching Individual Goals in Serum Phosphorus (Steering) No drug interventions Not Available Not Available completed NCT02151643
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease treatment 2 completed NCT05764590
A Study to Evaluate Safety and Efficacy of AP-306 in Hyperphosphatemia Patients treatment 2 completed NCT01850602
A Phase III Study of PA21 in Hemodialysis Patients With Hyperphosphatemia treatment 3 completed NCT01200784
Nicotinamide in Hemodialysis Patients With Hyperphosphatemia treatment 2 completed NCT02836184
Nicotinic Acid in Hemodialysis Patients With Hyperphosphatemia treatment 4 unknown_status NCT02684643
Study of Individualized Therapy on Hyperphosphatemia in Maintenance Hemodialysis Patients No drug interventions treatment Not Available completed NCT02940743
Behavioral Management of Phosphorus in Hemodialysis Patients No drug interventions treatment Not Available completed NCT03824587
Study to Evaluate the Efficacy of Tenapanor as Adjunctive Therapy to Phosphate Binder Therapy treatment 2 / 3 completed NCT02965053
A Phase1 Study to Explore the Safety of EOS789 in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis treatment 1 completed NCT03861247
Individualized Treatment of Hyperphosphatemia in Maintenance Hemodialysis Patients No drug interventions treatment 3 completed NCT04922645
Auryxia (Ferric Citrate) Therapy for In-Center and Home Dialysis Participants treatment 4 completed NCT03864445
Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients No drug interventions treatment 2 completed NCT04766398
Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis No drug interventions treatment 3 completed NCT01329497
The Effect of Systemic Dietary Instruction on Management of Plasma Phosphorus Levels in Peritoneal Dialysis (PD) Patients No drug interventions treatment Not Available unknown_status NCT04549597
Study to Evaluate the Use of Tenapanor as Core Therapy in the Treatment of Hyperphosphatemia treatment 4 completed NCT02755961
Efficacy of Dietary Education and Education on Phosphate Binder Use in Hemodialysis Patients No drug interventions supportive_care Not Available completed NCT01039428
A Study of HS219 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia No drug interventions treatment 2 completed NCT01187628
Long-term Study in Chronic Kidney Disease (Extension From Study 14817) treatment 3 completed NCT03001011
Evaluation of Renvela in Patients With Chronic Kidney Disease Not On Dialysis And Hyperphosphatemia In China treatment 3 completed NCT03305471
DS2330b Alone and With Sevelamer in Patients on Chronic Hemodialysis treatment 1 completed NCT01252771
Phosphate Kinetic Modeling 2 No drug interventions treatment 4 completed NCT00211978
EPIC(Effect of PhosLo on Phosphorus Levels in Chronic Kidney Disease) treatment 3 completed NCT01319578
PD Study to Assess Phosphate Binding Characteristics of K2CG Chewing Gum No drug interventions Not Available Not Available completed NCT05577507
Efficacy and Safety of Cholestyramine in the Management of Hyperphosphatemia in Adult Hemodialysis Patients treatment 4 completed NCT03831607
A Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on HD treatment 2 completed NCT03202407
Hyperphosphatemia in Children With Chronic Kidney Disease treatment 3 unknown_status NCT01742585
A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis treatment 3 completed NCT04579315
Long-term Effects of the New Nordic Renal Diet in Patients With Moderate Chronic Kidney Disease No drug interventions treatment Not Available completed NCT00767637
Long-term Treatment on BAY77-1931 (Lanthanum Carbonate) to Measure Lanthanum Concentrations in Bone treatment 2 completed NCT00364000
Arterial Stiffness and Calcifications in Haemodialysis Patients on Sevelamer or Calcium Acetate treatment Not Available withdrawn NCT00583570
Phosphorus Improvement Pilot Study No drug interventions health_services_research Not Available completed NCT00892749
Long-term Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis treatment 3 completed NCT00506441
A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia treatment 3 completed NCT00681941
An Open Label Dose Titration of Sevelamer Carbonate Tabs 3 Times a Day in Hyperphosphatemic CKD Patients Not On Dialysis treatment 3 completed NCT01814917
Long-term Extension Study of MCI-196 treatment 3 terminated NCT06186934
Post Marketing Surveillance Study to Observe Safety and Effectiveness of NEPHOXIL ® in S. Korea Patients No drug interventions Not Available Not Available recruiting NCT02081534
Dose Finding Study to Treat High Phosphate Levels in the Blood. treatment 2 completed NCT02237534
Lanthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and Hyperphosphatemia treatment 4 unknown_status NCT03864458
Dose-finding Study of KHK7791 in Hyperphosphatemia Patients No drug interventions treatment 2 completed NCT00542386
A Study of MCI-196 in Chronic Kidney Disease Subjects on Dialysis With Hyperphosphatemia and Dyslipidaemia treatment 3 completed NCT01074125
A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease treatment 3 completed NCT03427125
A Phase 3 Study of Tenapanor to Treat Hyperphosphatemia in ESRD Patients on Dialysis treatment 3 completed NCT00660530
Chewed vs. Crushed Lanthanum Carbonate in Hemodialysis Patients treatment 2 completed NCT03409757
Velphoro and Impact on the Oral Cavity and Gut Microbiome Not Available Not Available terminated NCT01574326
An Efficacy and Safety Study of Sevelamer Carbonate in Hyperphosphatemic Pediatric Participants With Chronic Kidney Disease treatment 2 completed NCT02492620
Ferric Citrate for the Transition From CKD Stage 4/5 to CKD Stage 5D treatment 3 completed NCT00742820
Bioequivalence Study Comparing Calcium Acetate Oral Solution Versus Calcium Acetate Gelcaps in Healthy Volunteers treatment 1 completed NCT03988920
A Long-Term Study of Tenapanor Alone or in Combination With Sevelamer in Patients With CKD on Dialysis and HP treatment 4 completed NCT01554982
A Long-Term Safety Extension Trial of Ferric Citrate in Patients With End-Stage Renal Disease (ESRD) on Dialysis treatment 3 completed NCT03163576
The Efficacy of Niacin on Hyperphosphatemia in Patients Undergoing Haemodialysis treatment 4 unknown_status NCT03984760
Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis treatment 3 completed NCT02687594
Non-interventional Study to Investigate the Short and Long Term Real-life Safety, Effectiveness, and Adherence of Velphoro® in Patients With Hyperphosphataemia Undergoing Haemodialysis (HD) or Peritoneal Dialysis (PD) Not Available Not Available completed NCT03573089
Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE) No drug interventions treatment Not Available recruiting NCT03236701
Egg White for Phosphorus Control in Haemodialysis Patients No drug interventions treatment Not Available unknown_status NCT01814904
Dose-finding Study of MCI-196 treatment 3 terminated NCT03079869
Transition to Ferric Citrate Among Hemodialysis and Peritoneal Dialysis Patients supportive_care 4 completed NCT00374712
Klotho Gene Polymorphism in Dialyzed Patients With Hyperphosphatemia No drug interventions Not Available Not Available terminated NCT04767581
Clinical Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis No drug interventions treatment 3 completed NCT02661295
A Study of Ferric Citrate to Improve Inflammation and Lipid Levels other 4 terminated NCT01191255
A 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on Dialysis prevention 3 completed NCT01003223
Phosphate Kinetic Modeling No drug interventions treatment Not Available completed NCT00557323
Long-term Effect of Lanthanum Carbonate on Bone Not Available Not Available completed NCT03256838
Assess the Safety and Efficacy of Nephoxil® in Subjects With End Stage Renal Disease (ESRD) on Dialysis other 4 completed NCT03367338
Low-Phosphate Diet and Fibroblast Growth Factor-23 Level No drug interventions treatment Not Available completed NCT04456803
Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis treatment 3 completed NCT02688764
A Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With Hyperphosphataemia treatment 3 terminated NCT03644264
PA21 Safety and Efficacy in Adult Chinese Subjects treatment 3 completed NCT05897502
Explore the Effectors of The Transtheoretical Model on Nutritional Education in Patients on Hemodialysis No drug interventions prevention Not Available completed NCT01696279
A Study to Assess the Pharmacokinetics of Lanthanum Carbonate, Investigate and Compare the Efficacy, Safety and Tolerability of Lanthanum Carbonate With Calcium Carbonate in Hyperphosphataemic Children and Adolescents With Chronic Kidney Disease on Dialysis treatment 2 completed NCT01965379
Effect of Restriction of Foods Containing Phosphorus Additives No drug interventions supportive_care Not Available completed NCT01518387
Open Study of BAY77-1931 (Lanthanum Carbonate) in Continuous Ambulatory Peritoneal Dialysis Patients treatment 3 completed NCT01818687
Safety and Tolerability Study of MCI-196 treatment 3 terminated NCT01514851
Phase III Double-blind Comparative Study of BAY77-1931 (Lanthanum Carbonate) With Calcium Carbonate treatment 3 completed NCT01412398
Fosrenol Post-marketing Surveillance for Continuous Cyclic Peritoneal Dialysis in Japan Not Available Not Available completed NCT02675998
An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD) treatment 3 completed NCT01742611
Long-term Study in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis treatment 3 completed NCT00967993
Trial of a New Formulation of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease Not Available Not Available completed NCT01755078
Long Term Evaluation of Sevelamer HCl vs. Calcium-based Phosphate Binder in the Treatment of Hyperphosphatemia in Hemodialysis Patients treatment 4 completed NCT01238588
The Effect(s) of Sevelamer Carbonate (Renvela) on Atherosclerotic Plaque Inflammation Judged by FDG-PET Scan treatment Not Available terminated NCT04766385
Clinical Study of KHK7791 in Hyperphosphatemia Patients on Peritoneal Dialysis No drug interventions treatment 3 completed NCT00508885
The Effect of Oral Niacinamide on Plasma Phosphorus Levels in Peritoneal Dialysis Patients treatment 1 / 2 completed NCT00542815
A Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia treatment 3 completed NCT00505037
A Phase 2 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis treatment 2 completed NCT01854437
The Effect of Magnesium Oxide on Plasma Phosphate in Hemodialysis Patients No drug interventions Not Available Not Available completed NCT04551300
A Phase 2 Study to Evaluate the Safety and Efficacy of VS-505(AP301) to Treat Hyperphosphatemia in Hemodialysis Patients treatment 2 completed NCT01578200
Outcome Study of Lanthanum Carbonate Compared With Calcium Carbonate in Hemodialysis Patients : Landmark Study treatment 3 completed NCT05085275
Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease treatment 3 completed NCT01503736
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Effects of Ferric Citrate in Subjects With End Stage Renal Disease treatment 3 completed NCT01725113
Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol treatment 4 terminated NCT01850641
A Phase III Study of PA21 With Calcium Carbonate in Hemodialysis Patients With Hyperphosphatemia No drug interventions treatment 3 completed NCT01245517
The Influence of Dietary Phosphorus Education Program on Nutritional Status and Serum Phosphate Level Among Hemodialysis Patient No drug interventions treatment Not Available unknown_status NCT04440696
To Evaluate the Patient Tolerance, Pharmacodynamics and Pharmacokinetics of Lanthanum Polystyrene Sulfonate Powder treatment 1 / 2 unknown_status NCT00769496
BAY 77-1931 Long-term Extension From Phase II Study No drug interventions treatment 2 completed NCT06206135
Multicenter, Open, Prospective, 48 Weeks, Observational Study ,Evaluate the Safety and Efficacy of Nephoxil Capsule No drug interventions Not Available Not Available recruiting NCT04046263
Effect of Velphoro on Serum Phosphate and Albumin in Peritoneal Dialysis Patients treatment 4 completed NCT01057186
Hypophosphatemic Rickets in Norway Not Available Not Available unknown_status NCT03594539
Phosphate Microvascular Study No drug interventions diagnostic Not Available unknown_status NCT00416520
A Phase III, Multicentre, Double-Blind, Placebo-Controlled Withdrawal Study in Patients With Hyperphosphatemia treatment 3 completed NCT00772382
Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia treatment 3 completed NCT01852682
A Phase III Study of PA21 in Peritoneal Dialysis Patients With Hyperphosphatemia No drug interventions treatment 3 completed NCT01419327
Fosrenol Post-marketing Surveillance for Hemodialysis in Japan Not Available Not Available completed NCT01955876
Fosrenol Post-marketing Surveillance in Japan Not Available Not Available completed NCT01053676
Bioequivalence Study of BAY77-1931 Granule treatment 1 completed NCT04789876
Effectiveness of The Phosphate Mobile App on Serum Phosphorus in Adult Hemodialysis Patients With Hyperphosphatemia No drug interventions treatment Not Available completed NCT02027662
Therapeutic Equivalence of OsvaRen® Tablets and OsvaRen® Granules treatment 2 / 3 completed NCT05439980
Improving Phosphate Control in Children With CKD No drug interventions Not Available Not Available recruiting NCT04771780
Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis No drug interventions treatment 3 completed NCT01110629
Study in Chronic Kidney Disease (CKD) Not on Dialysis treatment 3 completed NCT01069692
Placebo Versus SBR759 in Lowering Phosphate in Dialysis Patients No drug interventions treatment 3 completed NCT00648167
A Safety and Tolerability Study of Zerenex (Ferric Citrate) in Patients With End-Stage Renal Disease (ESRD) treatment 2 completed NCT02469467
A Dose Escalation Study of VS-505 in End Stage Renal Disease Patients Undergoing Hemodialysis No drug interventions treatment 1 / 2 unknown_status NCT00834301
An Open Label Trial to Evaluate the Effects of a Novel Renal Multivitamin on Inflammation and Other Biomarkers in Endstage Renal Disease Patients No drug interventions treatment 2 unknown_status NCT04278404
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) Not Available Not Available recruiting NCT00316472
The Effect of Oral Niacinamide on Serum Phosphorus Levels in Hemodialysis Patients treatment 1 completed NCT01976572
Drug-Drug Interaction Study to Evaluate the Effect of Colestilan on the Pharmacokinetics of Single Doses of Candesartan Cilexetil in Healthy Subjects treatment 1 completed NCT00833768
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Sevelamer Carbonate Tablets Dosed Three Times a Day in Hyperphosphataemic Chronic Kidney Disease Patients Not on Dialysis treatment 3 terminated NCT04256369
Rate of Termination of Premixed Parenteral Nutrition (PN) in Surgical Patients Secondary to High Serum Electrolytes No drug interventions Not Available Not Available completed NCT00451295
A Phase III, Multi-Centre, Randomised, Placebo-Controlled Study in Combination With Ca-based P Binders in Patients With Hyperphosphatemia treatment 3 terminated NCT00837655
Effect of Sevelamer on Glucose Tolerance and Insulin Sensitivity in Patients With Chronic Renal Failure (CKD) treatment Not Available withdrawn NCT00567723
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol) No drug interventions Not Available Not Available completed NCT03146923
Decreasing Intakes & Absorption of Phosphorus in Haemodialysis Patients Through Food Choices No drug interventions treatment Not Available completed NCT01057108
Double Blind Randomized Placebo Controlled Trial of FOSTRAP Chewing Gum in Patients With CKD and Hyperphosphatemia No drug interventions treatment 1 completed NCT01510106
Ferric Citrate in Patients With End-Stage Renal Disease on Dialysis treatment 3 completed